137 related articles for article (PubMed ID: 9031878)
1. Ceftibuten concentrations in human tonsillar tissue.
Scaglione F; Pintucci JP; Demartini G; Dugnani S
Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):940-3. PubMed ID: 9031878
[TBL] [Abstract][Full Text] [Related]
2. Concentrations of azithromycin in human tonsillar tissue.
Foulds G; Chan KH; Johnson JT; Shepard RM; Johnson RB
Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):853-6. PubMed ID: 1662631
[TBL] [Abstract][Full Text] [Related]
3. [Five days ceftibuten versus 10 days penicillin in the treatment of 2099 patients with A-streptococcal tonsillopharyngitis].
Adam D; Scholz H; Helmerking M
Fortschr Med Orig; 2001 Jul; 119 Suppl 2():63-70. PubMed ID: 15704358
[TBL] [Abstract][Full Text] [Related]
4. Correlation between plasma and tonsillar levels of cefroxadine.
Fraschini F; Scaglione F; Vago F; Bichisao E; Borghi C; Montanari M
Chemotherapy; 1988; 34(1):8-12. PubMed ID: 3349862
[TBL] [Abstract][Full Text] [Related]
5. Concentration of moxifloxacin in plasma and tonsillar tissue after multiple administration in adult patients.
Esposito S; Noviello S; D'Errico G; Motta G; Passali D; Aimoni C; Pilucchi S; Fallani S; Cassetta MI; Mazzei T; Novelli A
J Antimicrob Chemother; 2006 Apr; 57(4):789-92. PubMed ID: 16504997
[TBL] [Abstract][Full Text] [Related]
6. Penetration of cefprozil into tonsillar and adenoidal tissues.
Shyu WC; Reilly J; Campbell DA; Wilber RB; Barbhaiya RH
Antimicrob Agents Chemother; 1993 May; 37(5):1180-3. PubMed ID: 8517711
[TBL] [Abstract][Full Text] [Related]
7. Multiple-dose pharmacokinetics of ceftibuten after oral administration to healthy volunteers.
Bressolle F; Galtier M; Kinowski JM; Goncalves F; Edno L; Panis R; Gomeni R
J Pharm Sci; 1994 Sep; 83(9):1236-40. PubMed ID: 7830237
[TBL] [Abstract][Full Text] [Related]
8. Penetration of erythromycin into tonsillar tissue.
Falchi M; Teodori F; Carraro A; Cioce C; Scaglione F; Braga PC; Fraschini F
Curr Med Res Opin; 1985; 9(9):611-5. PubMed ID: 4053675
[TBL] [Abstract][Full Text] [Related]
9. Multiple-dose pharmacokinetics of ceftibuten in healthy volunteers.
Lin C; Radwanski E; Affrime M; Cayen MN
Antimicrob Agents Chemother; 1995 Feb; 39(2):356-8. PubMed ID: 7726497
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and tissue penetration of ceftibuten.
Wise R; Nye K; O'Neill P; Wostenholme M; Andrews JM
Antimicrob Agents Chemother; 1990 Jun; 34(6):1053-5. PubMed ID: 2393265
[TBL] [Abstract][Full Text] [Related]
11. Ceftibuten vs. penicillin V in group A beta-hemolytic streptococcal pharyngitis. Members of the Ceftibuten Pharyngitis International Study Group.
Pichichero ME; Mclinn SE; Gooch WM; Rodriguez W; Goldfarb J; Reidenberg BE
Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S102-7. PubMed ID: 7567309
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and dose proportionality of ceftibuten in men.
Lin C; Lim J; Radwanski E; Marco A; Affrime M
Antimicrob Agents Chemother; 1995 Feb; 39(2):359-61. PubMed ID: 7726498
[TBL] [Abstract][Full Text] [Related]
13. Concentration of phenoxymethylpenicillin in tonsillar tissue.
Roos K; Brorson JE
Eur J Clin Pharmacol; 1990; 39(4):417-8. PubMed ID: 2127570
[TBL] [Abstract][Full Text] [Related]
14. Clinical practice guideline: tonsillitis II. Surgical management.
Windfuhr JP; Toepfner N; Steffen G; Waldfahrer F; Berner R
Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):989-1009. PubMed ID: 26882912
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of iron and zinc levels in recurrent tonsillitis and tonsillar hypertrophy.
Somuk BT; Sapmaz E; Soyalıç H; Yamanoğlu M; Mendil D; Arici A; Gurbuzler L
Am J Otolaryngol; 2016; 37(2):116-9. PubMed ID: 26954864
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of the oral cephalosporins--a review.
Wise R
J Antimicrob Chemother; 1990 Dec; 26 Suppl E():13-20. PubMed ID: 2292525
[TBL] [Abstract][Full Text] [Related]
17. [Tonsillar and erythrocyte levels of superoxide dismutase in children with and without recurrent tonsillitis].
García Callejo FJ; Orts Alborch MH; Morant Ventura A; Costa Alcácer I; Velert Vila MM; Blay Galaud L
An Esp Pediatr; 2002 Apr; 56(4):310-7. PubMed ID: 11927098
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of ceftibuten in children.
Barr WH; Affrime M; Lin CC; Batra V
Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S93-101. PubMed ID: 7567317
[TBL] [Abstract][Full Text] [Related]
19. Ceftibuten pharmacokinetics and pharmacodynamics. Focus on paediatric use.
Kearns GL; Young RA
Clin Pharmacokinet; 1994 Mar; 26(3):169-89. PubMed ID: 8194281
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics of ceftibuten in humans.
Barr WH; Lin CC; Radwanski E; Lim J; Symchowicz S; Affrime M
Diagn Microbiol Infect Dis; 1991; 14(1):93-100. PubMed ID: 2013216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
